Eris Lifesciences Limited ERIS.NS · Stock Open Eris Lifesciences Limited in new tab
Analyst price targets
Recent rating changes, newest first
Eris Lifesciences Limited Analysis (ERIS.NS)
Is Eris Lifesciences Limited a good investment? Eris Lifesciences Limited (ERIS.NS) is currently trading at 1149.80 INR. Market analysts have a consensus price target of 1632.20 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 24.48. This valuation is generally in line with the broader market.
Earnings Schedule: Eris Lifesciences Limited is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is 57.71.
For income investors, Eris Lifesciences Limited pays a dividend yield of 0.63%.
Investor FAQ
Does Eris Lifesciences Limited pay a dividend?
Yes, it pays an annual dividend of 7.21 INR (0.63% yield).
What asset class is Eris Lifesciences Limited?
Eris Lifesciences Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of 47.26.
Company Profile
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, GLP-1, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram monitoring, continuous glucose monitoring system, sleep device, antenatal care, and early neuropathy screening solutions, as well as polycystic ovary syndrome screening, diagnosis, and management. The company offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
| Year | Total Dividends |
|---|---|
| ▸2027 |
7.21 INR
|
| June 7, 2027 (estimated) | 7.2100 |
| ▸2026 |
7.21 INR
|
| June 6, 2026 | 7.2100 |
| ▸2025 |
7.35 INR
|
| Feb. 28, 2025 | 7.3500 |
| ▸2022 |
7.35 INR
|
| Sept. 4, 2022 | 7.3500 |
| ▸2021 |
6.01 INR
|
| Aug. 28, 2021 | 6.0100 |
| ▸2020 |
8.37 INR
|
| Sept. 1, 2020 | 5.5000 |
| April 10, 2020 | 2.8700 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Eris Lifesciences Limited | Jun 06, 2026 | Paid | 7.21 INR |
Community Discussion